Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.
52W High
$4.99
52W Low
$1.02
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.10
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
0.00%
Shares Outstanding
0
Float
117,059,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-06-30 (Overview)
Revenue (TTM)
562,478,000
Gross Profit (TTM)
303,064,000
EPS (TTM)
N/A
Profit Margin (>10% good)
0.11%
Operating Margin (TTM) (higher better)
0.10%
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
-0.58
Revenue YoY (Quarterly) (>8% good)
-0.13
Momentum
Bearish momentumValue
-0.1198
Previous
-0.1076
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025